GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Shares Buyback Ratio %

Hemogenyx Pharmaceuticals (LSE:HEMO) Shares Buyback Ratio % : -19.26 (As of Jul. 22, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Hemogenyx Pharmaceuticals's current shares buyback ratio was -19.26%.


Hemogenyx Pharmaceuticals Shares Buyback Ratio % Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals Shares Buyback Ratio % Chart

Hemogenyx Pharmaceuticals Annual Data
Trend Feb15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.04 -125.92 - -20.01 -19.26

Hemogenyx Pharmaceuticals Semi-Annual Data
Feb15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -16.58 -2.94 -14.15 -4.47

Hemogenyx Pharmaceuticals Shares Buyback Ratio % Calculation

Hemogenyx Pharmaceuticals's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(2.939 - 3.505) / 2.939
=-19.26%

Hemogenyx Pharmaceuticals's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(3.355 - 3.505) / 3.355
=-4.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemogenyx Pharmaceuticals Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Hemogenyx Pharmaceuticals's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemogenyx Pharmaceuticals Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of innovative treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments.

Hemogenyx Pharmaceuticals Headlines

No Headlines